NI200900157A - Derivados de azabicicloalcano, su preparación y su aplicación en terapéutica. - Google Patents

Derivados de azabicicloalcano, su preparación y su aplicación en terapéutica.

Info

Publication number
NI200900157A
NI200900157A NI200900157A NI200900157A NI200900157A NI 200900157 A NI200900157 A NI 200900157A NI 200900157 A NI200900157 A NI 200900157A NI 200900157 A NI200900157 A NI 200900157A NI 200900157 A NI200900157 A NI 200900157A
Authority
NI
Nicaragua
Prior art keywords
cycloalkyl
alkylene
aryl
group
heterocycloalkyl
Prior art date
Application number
NI200900157A
Other languages
English (en)
Inventor
Ben Ayad Omar
Leclerc Odile
Lochead Alistair
Saady Mourad
Slowinski Franck
Vache Julien
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38523491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NI200900157(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NI200900157A publication Critical patent/NI200900157A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Abstract

La invención se refiere a los compuestos de fórmula general (I) en la que R representa bien un átomo de hidrógeno o de halógeno; bien un grupo hidroxi, alcoxi (C1-C6), cicloalquilo (C3-C7) - O - o cicloalquilo (C3 - C7) - alquileno (C1 - C3) - O - ; bien un grupo heterocicloalquilo, arilo o heteroarilo; pudiendo estar este grupo sustituido opcionalmente con uno o varios grupo elegidos entre los átomos de halógeno, los grupos alquilo(C1 - C6), cicloalquilo (C3-C7), cicloalquilo (C3- C7) - alquileno (C1-C3), alcoxi (C1-C6), cicloalquilo (C3-C7) - O -, cicloalquilo (C3 - C7) - alquileno (C1-C3)-O-, fluoroalquilo (C1-C6), fluoroalcoxi (C1-C6), nitro, ciano, hydroxi, amino, alquilamino (C1-C6) o dialquilamino (C1-C6), heterocicloalquilo, arilo, arilo - alquileno(C1C6), heteroarilo, heteroarilo - alquileno (C1- C6), arilo-O-, -C(O) - alquilo (C1-C6), estando el grupo heterocicloalquilo sustituido opcionalmente con -C(O)O(CH3)3; n representa 1 ó 2; m representa 1 ó 2; o representa 1 ó 2; en el estado de base o de sal de adición a un ácido, así como en el estado de hidrato o de solvato. Procedimiento de preparación y aplicación en terapéutica.
NI200900157A 2007-02-09 2009-08-07 Derivados de azabicicloalcano, su preparación y su aplicación en terapéutica. NI200900157A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0700940A FR2912404B1 (fr) 2007-02-09 2007-02-09 Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
NI200900157A true NI200900157A (es) 2010-07-15

Family

ID=38523491

Family Applications (1)

Application Number Title Priority Date Filing Date
NI200900157A NI200900157A (es) 2007-02-09 2009-08-07 Derivados de azabicicloalcano, su preparación y su aplicación en terapéutica.

Country Status (40)

Country Link
US (2) US8173669B2 (es)
EP (1) EP2118104B1 (es)
JP (1) JP5356257B2 (es)
KR (1) KR101517629B1 (es)
CN (1) CN101605793B (es)
AR (1) AR065248A1 (es)
AU (1) AU2008224785B2 (es)
BR (1) BRPI0806969A2 (es)
CA (1) CA2677713C (es)
CL (1) CL2008000394A1 (es)
CO (1) CO6220857A2 (es)
CR (1) CR10969A (es)
CY (1) CY1113896T1 (es)
DK (1) DK2118104T3 (es)
DO (1) DOP2009000186A (es)
EA (1) EA017802B1 (es)
EC (1) ECSP099568A (es)
ES (1) ES2402328T3 (es)
FR (1) FR2912404B1 (es)
GT (1) GT200900206A (es)
HK (1) HK1139671A1 (es)
HN (1) HN2009001484A (es)
HR (1) HRP20130279T1 (es)
IL (1) IL199966A (es)
MA (1) MA31233B1 (es)
MX (1) MX2009008492A (es)
MY (1) MY161067A (es)
NI (1) NI200900157A (es)
NZ (1) NZ578673A (es)
PE (1) PE20081664A1 (es)
PL (1) PL2118104T3 (es)
PT (1) PT2118104E (es)
SI (1) SI2118104T1 (es)
SV (1) SV2009003347A (es)
TN (1) TN2009000314A1 (es)
TW (1) TWI395585B (es)
UA (1) UA97833C2 (es)
UY (1) UY30908A1 (es)
WO (1) WO2008110699A2 (es)
ZA (1) ZA200905511B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR063142A1 (es) * 2006-10-04 2008-12-30 Pharmacopeia Inc Derivados de 2-(bencimidazolil) purina y purinonas 6-sustituidas utiles como inmunosupresores,y composiciones farmaceuticas que los contienen.
RU2537390C1 (ru) * 2013-07-02 2015-01-10 Федеральное государственное унитарное предприятие "Государственный завод медицинских препаратов" Способ получения 2-экзо-[3'-(6'-хлорпиридил)]-7-азабицикло[2.2.1]-гептана
WO2016015333A1 (en) * 2014-08-01 2016-02-04 F.Hoffmann-La Roche Ag 2-oxa-5-azabicyclo [2.2.1] heptan-3-yl derivatives
CN111777593A (zh) * 2019-04-03 2020-10-16 南京天印健华医药科技有限公司 作为转染期间重排激酶抑制剂的新的化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610130D0 (en) * 1986-04-25 1986-05-29 Wellcome Found Pesticidal compounds
AU7474794A (en) * 1993-07-22 1995-02-20 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
CA2526204A1 (en) 2003-06-12 2004-12-23 Novo Nordisk A/S Pyridinyl carbamates as hormone-sensitive lipase inhibitors
FR2889701B1 (fr) * 2005-08-12 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.

Also Published As

Publication number Publication date
US8759343B2 (en) 2014-06-24
DOP2009000186A (es) 2009-09-15
FR2912404A1 (fr) 2008-08-15
TN2009000314A1 (fr) 2010-12-31
CY1113896T1 (el) 2016-07-27
ES2402328T3 (es) 2013-04-30
IL199966A0 (en) 2010-04-15
PE20081664A1 (es) 2008-12-14
US20100035916A1 (en) 2010-02-11
GT200900206A (es) 2011-08-18
TWI395585B (zh) 2013-05-11
BRPI0806969A2 (pt) 2014-04-08
MA31233B1 (fr) 2010-03-01
CR10969A (es) 2009-10-23
HK1139671A1 (en) 2010-09-24
ZA200905511B (en) 2010-10-27
MY161067A (en) 2017-04-14
EA200970745A1 (ru) 2010-02-26
CA2677713C (fr) 2015-11-24
PT2118104E (pt) 2013-03-25
CN101605793B (zh) 2013-04-24
FR2912404B1 (fr) 2009-04-10
AR065248A1 (es) 2009-05-27
JP5356257B2 (ja) 2013-12-04
SI2118104T1 (sl) 2013-05-31
HRP20130279T1 (hr) 2013-04-30
CO6220857A2 (es) 2010-11-19
ECSP099568A (es) 2009-09-29
UY30908A1 (es) 2008-09-30
WO2008110699A2 (fr) 2008-09-18
CN101605793A (zh) 2009-12-16
AU2008224785B2 (en) 2013-03-14
KR20090106600A (ko) 2009-10-09
PL2118104T3 (pl) 2013-05-31
WO2008110699A3 (fr) 2009-01-15
EP2118104B1 (fr) 2013-01-02
KR101517629B1 (ko) 2015-05-04
TW200838519A (en) 2008-10-01
AU2008224785A1 (en) 2008-09-18
NZ578673A (en) 2011-12-22
MX2009008492A (es) 2009-09-28
US8173669B2 (en) 2012-05-08
JP2010518053A (ja) 2010-05-27
SV2009003347A (es) 2010-02-01
UA97833C2 (ru) 2012-03-26
EP2118104A2 (fr) 2009-11-18
CL2008000394A1 (es) 2008-06-13
DK2118104T3 (da) 2013-04-08
EA017802B1 (ru) 2013-03-29
HN2009001484A (es) 2012-01-16
US20120202807A1 (en) 2012-08-09
CA2677713A1 (fr) 2008-09-18
IL199966A (en) 2014-11-30

Similar Documents

Publication Publication Date Title
UY30603A1 (es) Derivados de 2-aril-6-fenil-imidazo[1, 2-a]piridinas, su preparacion y su aplicacion en terapéutica
DOP2010000230A (es) Derivados de urea de tetrahidroquinoxalina, su preparacion y su aplicacion en terapeutica
CO6300864A2 (es) Derivados polisustituidos de 6-heteroaril-imidazo[1,2-a]piridinas su preparacion y su aplicacion en terapeutica
ECSP099395A (es) Nuevos derivados de los ácidos amino-nicotínico y amino-isonicotínico
CU23706B7 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
CO6300865A2 (es) Derivados polisustituidos de 2 aril-6-fenil-imidazo[1,2-a]piridinas su preparacion y su aplicacion en terapeutica
CO6150179A2 (es) Derivados de n-(amino-heteroaril)-1h-hindol-2-carboxamidas su preparacion y su aplicacion en terapeutica
CO6300867A2 (es) Derivados polisustituidos de 2 -heteroaril-6-fenil-imidazo[1,2-a]piridinas su preparacion y su aplicacion en terapeutica
DOP2010000046A (es) Compuestos de biciclolactama sustituida
CO6150146A2 (es) Derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas su preparacion y su aplicacion en terapeutica
NI200800015A (es) Derivados de n-(heteroaril)-1-heteroarilalquil - 1h - indol - 2 - carboxamidas, su preparación y su aplicación en terapéutica.
CO6251295A2 (es) Nuevos derivados de carbazol inhibidores de hsp90 composiciones que los contienen y utilizacion
AR074021A1 (es) Compuestos heterociclicos fusionados como moduladores del canal ionico
CO6251235A2 (es) Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica
CU23761B7 (es) Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
AR069083A1 (es) Derivados heterociclicos de 1,3-tiazol inhibidores de proteinquinasas, composiciones farmaceuticas que los contienen y usos de los mismos en el tratamiento o prevencion de trastornos proliferativos.
AR082004A1 (es) Compuestos de fusion de piridina
CO6150147A2 (es) Derivados de 5,6-bisaril-2-piridin-carboxamida su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de urotensina ii
AR066605A1 (es) Derivados de heteroarilamida pirimidona
AR073043A1 (es) Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras.
CO6400145A2 (es) Derivados de 2-piridin-2-il pirazol-3(2h) -ona, su preparción y su aplicación terapeútica
NI200900157A (es) Derivados de azabicicloalcano, su preparación y su aplicación en terapéutica.
CO6160310A2 (es) Nuevos derivados imidazolonas su preparacion como medicamentos composiciones farmaceuticas utilizacion como inhibidores de proteinas quinasas principalmente cdc7
AR083861A1 (es) OXAZOLIDINONAS COMO MODULADORES DE mGluR5 Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
HN2009000504A (es) Derivados de pirrolizina, indolizina y quinolizina su preparacion y su aplicacion en terapeutica.